Evidence map›Paper›PMID 37205934›Full record

ArticleHealth science reports2023

Investigation of the effect of Low-Level Laser Therapy on arm lymphedema in breast cancer patients: A noninvasive treatment for an intractable morbidity.

Farshid Farhan, Mahmood Samei, Alireza Abdshah, Ali Kazemian, Shahriar Shahriarian, Farnaz Amouzegar-Hashemi, Mostafa Farzin, Reza Ghalehtaki, Fatemeh Jafari, Francesco Cuccia

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Farshid FarhanRadiation Oncology Research Center (RORC), Cancer Institute Tehran University of Medical Sciences Tehran Iran.
Mahmood SameiRadiation Oncology Research Center (RORC), Cancer Institute Tehran University of Medical Sciences Tehran Iran.
Alireza AbdshahSchool of Medicine Tehran University of Medical Sciences Tehran Iran.ORCID 0000-0002-8411-9927
Ali KazemianRadiation Oncology Research Center (RORC), Cancer Institute Tehran University of Medical Sciences Tehran Iran.
Shahriar ShahriarianDepartment of Radiology, Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran Iran.
Farnaz Amouzegar-HashemiRadiation Oncology Research Center (RORC), Cancer Institute Tehran University of Medical Sciences Tehran Iran.
Mostafa FarzinBrain and spinal cord injury research center, Neuroscience Institute Tehran University of Medical Sciences Tehran Iran.
Reza GhalehtakiRadiation Oncology Research Center (RORC), Cancer Institute Tehran University of Medical Sciences Tehran Iran.
Fatemeh JafariRadiation Oncology Research Center (RORC), Cancer Institute Tehran University of Medical Sciences Tehran Iran.
Francesco CucciaAdvanced Radiation Oncology Department Sacro Cuore Don Calabria Hospital Negrar Veneto Italy.
Tehran University of Medical Sciences · IRImam Khomeini Hospital · IROspedale Sacro Cuore Don Calabria · ITUniversity of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This article aims to study the effect of Low-Level Laser Therapy (LLLT) on arm lymphedema in patients who have breast cancer. Methods and Materials: Twenty-three patients were selected in a nonrandomized phase-2 clinical trial. After measuring the circumference of the affected and unaffected limbs at 6-points, the volume of the limbs, the degree of mental symptoms on visual analog scale by the patient upon entering the study, and performing an ultrasound on the patient's axilla to locate the fibrotic areas, a low-level laser device at a therapeutic dose of 2 J/cm Results: We noted that the average reductions in the circumference and volume of the affected limb, as compared with the unaffected limb, were about 16% and 21.7%, respectively, and improvement in the patient's mental symptoms was about 32%. Another notable observation was the great enthusiasm of most patients to continue their treatment, particularly from the second cycle onward. Conclusions: LLLT can, at least in association with current standard methods, be used for arm lymphedema to introduce further reductions in pain and volume.

Indexed as

breast cancerlow‐level laserlymphedema

Identifiers

PMID37205934
PMCPMC10189865
OpenAlexW4377042418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.